Professional Summary
Professional Overview
Andrew Lukowiak is a seasoned life sciences executive with over 20 years of experience driving innovation and strategic growth in the diagnostics and genomics industries. As the Chief Innovation Officer at NeoGenomics Laboratories, he is responsible for spearheading the company's research and development initiatives, leveraging his deep technical expertise and visionary leadership to develop cutting-edge diagnostic solutions.
Experience Summary
Current Role
In his current role as Chief Innovation Officer at NeoGenomics Laboratories, Andrew is responsible for guiding the company's innovative efforts, overseeing the development of new diagnostic tests and technologies. He plays a pivotal role in shaping the organization's strategic vision, ensuring that NeoGenomics remains at the forefront of the genomics and diagnostics landscape.
Career Progression
Prior to joining NeoGenomics, Andrew served as the President and Chief Scientific Officer at Talis Biomedical Corporation, where he led the company's efforts to develop advanced molecular diagnostic solutions. He has also held leadership positions at Epigenomics AG, Millennium Health, AltheaDx, GenMark Diagnostics, and Hologic, where he consistently demonstrated his ability to drive innovation, operational excellence, and commercial success.
Throughout his career, Andrew has made significant contributions to the advancement of diagnostic technologies, with a particular focus on molecular diagnostics and genomics. His extensive industry experience and technical expertise have allowed him to spearhead the development of numerous innovative products and solutions that have had a measurable impact on patient care and clinical decision-making.
Academic Background
Andrew holds a Bachelor of Science degree in Chemistry from the University of Wisconsin-Madison, where he graduated with distinction. His academic achievements and specialized training have provided a strong foundation for his successful career in the life sciences industry.
Areas of Expertise
- Diagnostic assay and test development
- Molecular diagnostics and genomics
- Strategic planning and innovation management
- Operational and financial optimization
- Cross-functional team leadership and collaboration
Professional Impact
Under Andrew's leadership, the organizations he has served have achieved notable milestones, including the successful commercialization of several diagnostic products, the expansion of market reach, and the enhancement of operational efficiency. His contributions have been instrumental in driving growth, improving patient outcomes, and advancing the overall diagnostic and genomics industries.
Conclusion
Andrew Lukowiak is a respected and accomplished life sciences executive with a proven track record of driving innovation and strategic growth. As the Chief Innovation Officer at NeoGenomics Laboratories, he is poised to continue his impressive career trajectory, leveraging his deep technical expertise and visionary leadership to propel the company's research and development initiatives and deliver transformative diagnostic solutions to the market.
